190 related articles for article (PubMed ID: 29846705)
21. Deep Neural Network Analysis of Pathology Images With Integrated Molecular Data for Enhanced Glioma Classification and Grading.
Pei L; Jones KA; Shboul ZA; Chen JY; Iftekharuddin KM
Front Oncol; 2021; 11():668694. PubMed ID: 34277415
[TBL] [Abstract][Full Text] [Related]
22. Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization.
Wang W; Li T; Cheng Y; Li F; Qi S; Mao M; Wu J; Liu Q; Zhang X; Li X; Zhang L; Qi H; Yang L; Yang K; He Z; Ding S; Qin Z; Yang Y; Yang X; Luo C; Guo Y; Wang C; Liu X; Zhou L; Liu Y; Kong W; Miao J; Ye S; Luo M; An L; Wang L; Che L; Niu Q; Ma Q; Zhang X; Zhang Z; Hu R; Feng H; Ping YF; Bian XW; Shi Y
Cancer Cell; 2024 May; 42(5):815-832.e12. PubMed ID: 38640932
[TBL] [Abstract][Full Text] [Related]
23. The association between calreticulin and glucagon-like peptide-1 expressions with prognostic factors in high-grade gliomas.
Baran O; Akgun MY; Kayhan A; Evran S; Ozbek A; Akyoldas G; Samanci MY; Demirel N; Sonmez D; Serin H; Kocak A; Kemerdere R; Tanriverdi T
J Cancer Res Ther; 2024 Jan; 20(1):25-32. PubMed ID: 38554294
[TBL] [Abstract][Full Text] [Related]
24. A noncoding single-nucleotide polymorphism at 8q24 drives
Yanchus C; Drucker KL; Kollmeyer TM; Tsai R; Winick-Ng W; Liang M; Malik A; Pawling J; De Lorenzo SB; Ali A; Decker PA; Kosel ML; Panda A; Al-Zahrani KN; Jiang L; Browning JWL; Lowden C; Geuenich M; Hernandez JJ; Gosio JT; Ahmed M; Loganathan SK; Berman J; Trcka D; Michealraj KA; Fortin J; Carson B; Hollingsworth EW; Jacinto S; Mazrooei P; Zhou L; Elia A; Lupien M; He HH; Murphy DJ; Wang L; Abyzov A; Dennis JW; Maass PG; Campbell K; Wilson MD; Lachance DH; Wrensch M; Wiencke J; Mak T; Pennacchio LA; Dickel DE; Visel A; Wrana J; Taylor MD; Zadeh G; Dirks P; Eckel-Passow JE; Attisano L; Pombo A; Ida CM; Kvon EZ; Jenkins RB; Schramek D
Science; 2022 Oct; 378(6615):68-78. PubMed ID: 36201590
[TBL] [Abstract][Full Text] [Related]
25.
Kayabolen A; Yilmaz E; Bagci-Onder T
Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356864
[TBL] [Abstract][Full Text] [Related]
26. Constitutive type-1 interferons signaling activity in malignant gliomas.
Li C; Long L; Wang Y; Chi X; Zhang P; Zhang Y; Ji N
J Neurooncol; 2024 Jul; 168(3):381-391. PubMed ID: 38789844
[TBL] [Abstract][Full Text] [Related]
27. Molecular fingerprinting reflects different histotypes and brain region in low grade gliomas.
Mascelli S; Barla A; Raso A; Mosci S; Nozza P; Biassoni R; Morana G; Huber M; Mircean C; Fasulo D; Noy K; Wittemberg G; Pignatelli S; Piatelli G; Cama A; Garré ML; Capra V; Verri A
BMC Cancer; 2013 Aug; 13():387. PubMed ID: 23947815
[TBL] [Abstract][Full Text] [Related]
28. Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Response.
Bhatia A; Moreno R; Reiner AS; Nandakumar S; Walch HS; Malani R; Panageas KS; Mellinghoff IK; Bale TA; Young RJ
Clin Cancer Res; 2024 Feb; 30(3):639. PubMed ID: 38298142
[No Abstract] [Full Text] [Related]
29. Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Letter.
Mandonnet E
Clin Cancer Res; 2024 Feb; 30(3):638. PubMed ID: 38298141
[No Abstract] [Full Text] [Related]
30. The effect Of vascular related CeRNA genes and corresponding imaging biomarkers on survival in lower grade glioma.
Guo Y; Guo H; Tong H; Xue W; Xie T; Wang L; Tong H
Ir J Med Sci; 2024 Apr; 193(2):653-663. PubMed ID: 37801268
[TBL] [Abstract][Full Text] [Related]
31. Primary orthotopic glioma xenografts recapitulate infiltrative growth and isocitrate dehydrogenase I mutation.
Valadez JG; Sarangi A; Lundberg CJ; Cooper MK
J Vis Exp; 2014 Jan; (83):e50865. PubMed ID: 24458098
[TBL] [Abstract][Full Text] [Related]
32. Epilepsy in gliomas: recent insights into risk factors and molecular pathways.
Rudà R; Bruno F; Pellerino A
Curr Opin Neurol; 2023 Dec; 36(6):557-563. PubMed ID: 37865836
[TBL] [Abstract][Full Text] [Related]
33. GPR27 expression correlates with prognosis and tumor progression in gliomas.
Cai C; Hu L; Wu K; Liu Y
PeerJ; 2024; 12():e17024. PubMed ID: 38638156
[TBL] [Abstract][Full Text] [Related]
34. Glutathione metabolism-related gene signature predicts prognosis and treatment response in low-grade glioma.
Deng Z; Luo J; Ma J; Jin YN; Yu YV
Aging (Albany NY); 2024 May; 16(11):9518-9546. PubMed ID: 38819225
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas.
Tuysuz EC; Mourati E; Rosberg R; Moskal A; Gialeli C; Johansson E; Governa V; Belting M; Pietras A; Blom AM
J Exp Clin Cancer Res; 2024 Apr; 43(1):98. PubMed ID: 38561856
[TBL] [Abstract][Full Text] [Related]
36. Integrative spatial analysis reveals a multi-layered organization of glioblastoma.
Greenwald AC; Darnell NG; Hoefflin R; Simkin D; Mount CW; Gonzalez Castro LN; Harnik Y; Dumont S; Hirsch D; Nomura M; Talpir T; Kedmi M; Goliand I; Medici G; Laffy J; Li B; Mangena V; Keren-Shaul H; Weller M; Addadi Y; Neidert MC; Suvà ML; Tirosh I
Cell; 2024 May; 187(10):2485-2501.e26. PubMed ID: 38653236
[TBL] [Abstract][Full Text] [Related]
37. Low- and high-grade glioma-associated vascular cells differentially regulate tumor growth.
Muthukrishnan SD; Qi H; Wang D; Elahi L; Pham A; Alvarado AG; Li T; Gao F; Kawaguchi R; Lai A; Kornblum HI
Mol Cancer Res; 2024 Mar; ():. PubMed ID: 38441553
[TBL] [Abstract][Full Text] [Related]
38. Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling.
Anastasaki C; Chatterjee J; Cobb O; Sanapala S; Scheaffer SM; De Andrade Costa A; Wilson AF; Kernan CM; Zafar AH; Ge X; Garbow JR; Rodriguez FJ; Gutmann DH
Acta Neuropathol Commun; 2022 Aug; 10(1):120. PubMed ID: 35986378
[TBL] [Abstract][Full Text] [Related]
39. The spectrum of microvascular patterns in adult diffuse glioma and their correlation with tumor grade.
Soni ; Walke V; Joshi D; Sharma T; Shrivastava A; Agrawal A
J Pathol Transl Med; 2024 May; 58(3):127-133. PubMed ID: 38766738
[TBL] [Abstract][Full Text] [Related]
40. The Clinical Utility of a Tiered Approach to Pediatric Glioma Molecular Characterization for Resource-Limited Settings.
Hammad R; Nobre L; Ryall S; Arnoldo A; Siddaway R; Bennett J; Tabori U; Hawkins C
JCO Glob Oncol; 2024 May; 10():e2300269. PubMed ID: 38754050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
